Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Ketoprofen 200mg modified-release capsules
1001010L0AAAJAJ
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | 1,612 |
|
Ketoprofen 100mg modified-release capsules
1001010L0AAAIAI
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | 1,113 |
|
Ketoprofen 100mg suppositories
1001010L0AAAPAP
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | 1 |
|
Ketoprofen 100mg / Omeprazole 20mg modified-release capsules
1001010L0AAAMAM
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 100mg capsules
1001010L0AAABAB
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 100mg/2ml solution for injection ampoules
1001010L0AAAGAG
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 150mg modified-release capsules
1001010L0AAALAL
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 200mg / Omeprazole 20mg modified-release capsules
1001010L0AAANAN
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
|
Ketoprofen 50mg capsules
1001010L0AAAAAA
|
Ketoprofen (Systemic) | Ketoprofen | Musculoskeletal and Joint Diseases | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.